等待開盤 10-29 09:30:00 美东时间
-3.034
-1.77%
Morgan Stanley analyst Michael Cyprys maintains Virtus Inv (NYSE:VRTS) with a Underweight and raises the price target from $170 to $173.
10-28 23:29
On CNBC's "Halftime Report," two experts, Bryn Talkington and Jim Lebenthal, named Alphabet as their final trade.
10-28 19:51
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
10-28 10:08
Virtus Inv (NASDAQ:VRTS) reported quarterly earnings of $6.69 per share which missed the analyst consensus estimate of $6.77 by 1.21 percent. This is a 3.32 percent decrease over earnings of $6.92 per share from the same
10-24 19:04
Companies Reporting Before The Bell • Eni (NYSE:E) is expected to report quarte...
10-24 16:32
Virtus Inv (NASDAQ:VRTS) is gearing up to announce its quarterly earnings on Fr...
10-23 23:03
今日重点评级关注:摩根大通:维持Cogent Biosciences"超配"评级,目标价从30美元升至44美元;Piper Sandler:维持Vital Energy"中性"评级,目标价从16美元升至30美元
10-22 10:10
Barclays analyst Benjamin Budish maintains Virtus Inv (NYSE:VRTS) with a Underweight and lowers the price target from $190 to $175.
10-21 20:06
为缓解投资者的担忧,云服务供应商甲骨文(Oracle)继续“画饼”,但华尔街没有完全买账。 近日,甲骨文联席CEO克莱·马古伊克(Clay Magouyrk)在...
10-20 18:24
Jim Lebenthal picked BlackRock as his final trade on CNBC's Halftime Report. SoFi's Liz Young Thomas chose iShares Russell 2000 ETF while Stephanie Link named Victoria's Secret & Co.
10-16 20:27